Tafamidis for a Transplant Patient with Transthyretin Amyloid Polyneuropathy
Open Access
- 1 January 2017
- journal article
- Published by Korean Neurological Association in Journal of Clinical Neurology
- Vol. 13 (4) , 444-446
Abstract
Romero-Imbroda J, et al. J Clin Neurol. 2017 Oct;13(4):444-446. https://doi.org/10.3988/jcn.2017.13.4.444Keywords
This publication has 8 references indexed in Scilit:
- Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosisNeurology, 2016
- Transthyretin-type cerebral amyloid angiopathy: a serious complication in post-transplant patients with familial amyloid polyneuropathyJournal of Neurology, Neurosurgery & Psychiatry, 2014
- Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathyJournal of Neurology, 2013
- Liver transplantation and transthyretin amyloidosisMuscle & Nerve, 2012
- Progression of transthyretin amyloid neuropathy after liver transplantationNeurology, 2010
- Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatmentAmyloid, 2010
- Familial amyloid polyneuropathyJournal of the Neurological Sciences, 2009
- Transthyretin-associated neuropathic amyloidosisNeurology, 2001